The efficacy and safety of cannabidiol (CBD) in pediatric patients with Dravet Syndrome: a narrative review of clinical trials

Abstract Background Dravet Syndrome (DS) is a rare and severe form of childhood epilepsy that is often refractory to conventional antiepileptic drugs. Emerging evidence suggests that Cannabidiol (CBD) offer therapeutic benefits for DS. This review aims to evaluate the efficacy and safety of CBD in p...

Full description

Bibliographic Details
Published in:European Journal of Medical Research
Main Authors: Nicholas Aderinto, Gbolahan Olatunji, Emmanuel Kokori, Yusuf Ismaila Ajayi, Olumide Akinmoju, Abiola Samuel Ayedun, Oluwapelumi Ikeoluwa Ayoola, Noah Oluwaseun Aderinto
Format: Article
Language:English
Published: BMC 2024-03-01
Subjects:
Dravet Syndrome
Cannabidiol (CBD)
Pediatric patients
Seizure frequency
Antiepileptic drugs
Online Access:https://doi.org/10.1186/s40001-024-01788-6

Internet

https://doi.org/10.1186/s40001-024-01788-6

Similar Items